D Pharm

522 total citations
17 papers, 446 citations indexed

About

D Pharm is a scholar working on Molecular Medicine, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, D Pharm has authored 17 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Medicine, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Pharmacology. Recurrent topics in D Pharm's work include Antibiotic Resistance in Bacteria (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). D Pharm is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). D Pharm collaborates with scholars based in United States, Japan and France. D Pharm's co-authors include Kurt W. Kohn, Akira Fujimori, Mark R. Fesen, Éric Solary, Richard Bertrand, Yves Pommier, Glenda Kohlhagen, Gregory L. Kearns, Bettina C. Hilman and John T. Wilson and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, The Journal of Pediatrics and The Pediatric Infectious Disease Journal.

In The Last Decade

D Pharm

17 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Pharm United States	7	189	149	121	116	66	17	446
Masayasu Sekiguchi Japan	8	133 0.7×	31 0.2×	167 1.4×	90 0.8×	27 0.4×	8	356
Rasoul Raesi Iran	12	245 1.3×	59 0.4×	26 0.2×	94 0.8×	18 0.3×	66	532
Lee Cc Taiwan	11	61 0.3×	47 0.3×	73 0.6×	38 0.3×	20 0.3×	43	339
J. Giráldez Spain	14	127 0.7×	33 0.2×	80 0.7×	136 1.2×	9 0.1×	26	435
Quanyun A. Xu United States	11	85 0.4×	33 0.2×	75 0.6×	73 0.6×	12 0.2×	48	368
Kun‐Pin Hsieh Taiwan	12	78 0.4×	47 0.3×	36 0.3×	53 0.5×	26 0.4×	22	430
Carter D. Brooks United States	14	52 0.3×	56 0.4×	148 1.2×	19 0.2×	48 0.7×	27	457
Fillastre Jp France	9	58 0.3×	44 0.3×	72 0.6×	37 0.3×	29 0.4×	81	316
Shenghua Sun China	16	369 2.0×	203 1.4×	34 0.3×	40 0.3×	51 0.8×	35	709
G Fredj France	11	84 0.4×	44 0.3×	68 0.6×	180 1.6×	23 0.3×	40	483

Countries citing papers authored by D Pharm

Since Specialization

Citations

This map shows the geographic impact of D Pharm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Pharm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Pharm more than expected).

Fields of papers citing papers by D Pharm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Pharm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Pharm. The network helps show where D Pharm may publish in the future.

Co-authorship network of co-authors of D Pharm

This figure shows the co-authorship network connecting the top 25 collaborators of D Pharm. A scholar is included among the top collaborators of D Pharm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Pharm. D Pharm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Sharma, Ram A., et al.. (2014). ESTIMATION OF TOTAL PHENOLIC, FLAVONOIDAL CONTENT AND EVALUATION OF ANTIOXIDANT ACTIVITY OF METHANOLIC EXTRACT OF MILLINGTONIA HORTENSIS LINN.. World Journal of Pharmacy and Pharmaceutical Sciences. 3(12). 1646–1655. 1 indexed citations

Pharm, D, et al.. (2014). A CONCISE REVIEW ON ORAL Ph INDEPENDENT CONTROLLED DRUG DELIVERY SYSTEM. 1 indexed citations

Bhandari, Anil, et al.. (2014). Development and Evaluation of Time Controlled Pulsatile Drug Delivery System of Ketoprofen.. 1 indexed citations

Pharm, D, et al.. (2014). INVESTIGATION OF CHEMICAL COMPOSITION OF FLUEGGEA LEUCOPYRUS (WILLD.). 4 indexed citations

Pharm, D, et al.. (2014). PHYTOCHEMICAL ANALYSIS OF ROOT, STEM AND LEAF EXTRACTS IN RUBIA CORDIFOLIA L. AN IMPORTANT MEDICINAL PLANT. 4 indexed citations

Mohajeri, Parviz, et al.. (2012). ANTIBIOTIC RESISTANCE OF CLINICAL ISOLATES OF ACINETOBACTER BAUMANNII IN HOSPITALS OF KERMANSHAH, IRAN DURING ONE YEAR. 19(4). 405–412. 1 indexed citations

Kourelis, Taxiarchis, et al.. (2011). Decitabine for Acute Myeloid Leukemia in a Patient Undergoing Hemodialysis. European Journal of Inflammation. 9(3). 289–292. 3 indexed citations

Tabata, Yasuhiko, et al.. (2003). Significant Role of Tissue Engineering in Regenerative Medicine. Journal of Hard Tissue Biology. 12(2). 33–43. 4 indexed citations

James, Laura P., Cindy D. Stowe, D Pharm, & Eric A. Argào. (1999). Gastric injury following copper sulfate ingestion. Pediatric Emergency Care. 15(6). 429–431. 8 indexed citations

10.

Pharm, D, et al.. (1998). Disposition and tissue distribution of boron after infusion of borocaptate sodium in patients with malignant brain tumors. International Journal of Radiation Oncology*Biology*Physics. 41(3). 631–638. 14 indexed citations

11.

Pharm, D, et al.. (1994). Influence of Asthma or Allergies on the Utilization of Health Care Resources and Quality of Life of College Students. Journal of Asthma. 31(4). 251–267. 30 indexed citations

12.

Pommier, Yves, D Pharm, Mark R. Fesen, et al.. (1994). Cellular Determinants of Sensitivity and Resistance to DNA Topoisomerase Inhibitors. Cancer Investigation. 12(5). 530–542. 196 indexed citations

13.

Garraffo, R. & D Pharm. (1994). Critères pharmacocinétiques du choix d'un antibiotique pour l'antibioprophylaxie en chirurgie. Annales Françaises d Anesthésie et de Réanimation. 13(5 Suppl). S34–S44. 3 indexed citations

14.

Morris, Richard J., et al.. (1991). Sensitivity of FEV₁Response Following One and Two Inhalations of Albuterol: A Pilot Study. Journal of Asthma. 28(5). 323–328. 1 indexed citations

15.

Munzenberger, Paul J., et al.. (1984). Individualization of tobramycin dosage in patients with cystic fibrosis. The Pediatric Infectious Disease Journal. 3(6). 526–529. 26 indexed citations

16.

Kearns, Gregory L., D Pharm, Bettina C. Hilman, & John T. Wilson. (1982). Dosing implications of altered gentamicin disposition in patients with cystic fibrosis. The Journal of Pediatrics. 100(2). 312–318. 90 indexed citations

17.

Pharm, D, et al.. (1982). Pharmacokinetics of tobramycin in cystic fibrosis. The Journal of Pediatrics. 100(2). 318–321. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact